Form 4 for ATRC AtriCure, Inc.

Accepted 2022-03-03 00:00:00 ET · period of report 2022-03-01 · accession 0001323885-22-000029 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2022-03-03	2022-03-01	ATRC	Noznesky Justin J	Chief Mktg, Strategy Off	A - Grant	$0.00	+14.6K	45.3K	+48%	$0
	2022-03-03	2022-03-01	ATRC	Noznesky Justin J	Chief Mktg, Strategy Off	F - Tax	$69.59	-7,474	37.8K	-16%	-$520.1K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-03-01	A	A	7,789	$0.00	38,478	D	—	—	(F1) The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The award had both a Company performance goal and a service period requirement, which were both met.
2	Common	Common Stock	2022-03-01	A	A	6,825	$0.00	45,303	D	—	—	(F2) The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant.
3	Common	Common Stock	2022-03-01	F	D	7,474	$69.59	37,829	D	—	—	(F3) The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award.